HIGHLIGHTS
- who: Aitor Benedicto et al. from the Department of Cell Biology and Histology, Faculty of Medicine and Nursery, University of the Basque Country, Leioa, Bizkaia, Spain have published the article: The Synthetic Cannabinoid URB447 Exerts Antitumor and Antimetastatic Effect in Melanoma and Colon Cancer, in the Journal: Pharmaceuticals 2022, 15, x FOR PEERwas REVIEW 7 of 11 measured in melanoma (A) and CRC cancer cells (B) in the presence of increasing concentra- of /2022/
- what: The authors aim to investigate the role of CB2 receptor during melanoma and colorectal cancer (CRC) aggressiveness and metastatic growth . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.